- Home
- NDRA vs LGHL Comparison
NDRA vs LGHL Comparison
Compare NDRA & LGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDRA
- LGHL
- Stock Information
- Founded
- NDRA 2007
- LGHL 2015
- Country
- NDRA United States
- LGHL Singapore
- Employees
- NDRA N/A
- LGHL N/A
- Industry
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- LGHL Investment Bankers/Brokers/Service
- Sector
- NDRA Health Care
- LGHL Finance
- Exchange
- NDRA Nasdaq
- LGHL Nasdaq
- Market Cap
- NDRA 3.6M
- LGHL 4.3M
- IPO Year
- NDRA 2017
- LGHL N/A
- Fundamental
- Price
- NDRA $6.01
- LGHL $0.16
- Analyst Decision
- NDRA Strong Buy
- LGHL
- Analyst Count
- NDRA 1
- LGHL 0
- Target Price
- NDRA $14,000.00
- LGHL N/A
- AVG Volume (30 Days)
- NDRA 36.2K
- LGHL 5.4M
- Earning Date
- NDRA 11-15-2024
- LGHL 01-28-2025
- Dividend Yield
- NDRA N/A
- LGHL N/A
- EPS Growth
- NDRA N/A
- LGHL N/A
- EPS
- NDRA N/A
- LGHL N/A
- Revenue
- NDRA N/A
- LGHL $13,659,110.00
- Revenue This Year
- NDRA N/A
- LGHL N/A
- Revenue Next Year
- NDRA N/A
- LGHL N/A
- P/E Ratio
- NDRA N/A
- LGHL N/A
- Revenue Growth
- NDRA N/A
- LGHL 11.35
- 52 Week Low
- NDRA $4.01
- LGHL $0.13
- 52 Week High
- NDRA $2,240.00
- LGHL $1.55
- Technical
- Relative Strength Index (RSI)
- NDRA 51.58
- LGHL 44.11
- Support Level
- NDRA $5.60
- LGHL $0.14
- Resistance Level
- NDRA $6.29
- LGHL $0.17
- Average True Range (ATR)
- NDRA 0.60
- LGHL 0.03
- MACD
- NDRA 0.02
- LGHL -0.00
- Stochastic Oscillator
- NDRA 27.29
- LGHL 10.64
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
About LGHL Lion Group Holding Ltd.
Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.